TOM CAVANAUGH
PEOPLE MO
Healthcare Digital takes a look at the executive moves signalling change at the industry’ s biggest players, including Sanofi, Danaher and J & J
WRITTEN BY: SAM ROBINSON
TOM CAVANAUGH
JOB FROM: COMPANY GROUP CHAIRMAN, NORTH AMERICA, JOHNSON & JOHNSON INNOVATIVE MEDICINE
JOB TO: EXECUTIVE VICE PRESIDENT, JOHNSON & JOHNSON INNOVATIVE MEDICINE
Johnson & Johnson’ s Innovative Medicine division is entering a new chapter under Tom’ s leadership, who succeeds retiring EVP Jennifer Taubert. Tom brings nearly three decades of biopharmaceutical experience to the role following 15 years in leadership positions at Celgene, alongside nine years at Johnson & Johnson. Tom says,“ As I step into this role in September, I am honored to build on the strong foundation she [ Jennifer ] has created and carry forward the momentum she has inspired.”
“ I am honored to build on the strong foundation she [ Jennifer ] has created”
18 September 2026